BASDAI

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
basdai
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Active disease≥ 4
  • Inactive/low≥ 0
Direct Clinical Answer

The BASDAI calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include fatigue. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Bath Ankylosing Spondylitis Disease Activity Index.

Clinical Indication

The BASDAI is indicated for bedside clinical practice to support Bath Ankylosing Spondylitis Disease Activity Index.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology.

Formula & Variables:

BASDAI = (Q1+Q2+Q3+Q4+mean(Q5,Q6))/5; total 0-10.

Input Parameters

NameTypeRequiredDescription
fatigueintYes0=none, 10=very severe
spinal_painintYes0=none, 10=very severe
joint_painintYes0=none, 10=very severe
enthesitisintYes0=none, 10=very severe
stiffness_severityintYes0=none, 10=very severe
stiffness_durationintYes0=none, 10=very severe

Score Interpretation & Guidance

RangeStageDescription
≥ 4Active diseaseActive disease
≥ 0Inactive/lowInactive or low activity

Evidence-Based References (EBM)

  • Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the BASDAI. J Rheumatol. 1994;21(12):2286-2291.

Related calculators